Endovascular Interventional Management of Cerebral Venous Sinus Thrombosis

Abstract

Cerebral venous sinus thrombosis (CVST) is relatively a rare cause of stroke and can have protean manifestations ranging from headache, seizures, diplopia, focal deficits or coma. It is usually managed with anticoagulation. However, various studies have shown a mortality of 13% to 30% and have elucidated certain risk factors such as poor sensorium at presentation and rapid deterioration in spite of anticoagulation, for poor outcomes. In these situations, it has been postulated that endovascular management using thrombolysis or mechanical thrombectomy can give better outcomes. This review tries to address the role of endovascular interventions in CVST.

A case report of extensive cerebral venous sinus thrombosis: a sequela of COVID-19?

“…Neuro-interventional procedures for the management of CVST are typically reserved for patients who demonstrate rapid deterioration. 11 For such cohort of patients, endovascular techniques including direct catheter thrombolysis and mechanical thrombectomy (with or without thrombolysis) are available. Currently there is paucity in evidence to recommend one procedure over another, nor are there any randomised controlled trials comparing these endovascular interventions with adjunct anticoagulation therapies.…”